関連コンテンツ
November 5, 2026
Smarter Drug Discovery: Turning Screening Hits into Opportunities
Sponsor:
RG Discovery
Pelago Bioscience
November 5, 2026
Improving Translational Decision-Making through Disease-Relevant Preclinical Models in Pulmonary Fibrosis and Pain Drug Discovery
Sponsor:
Axcelead Drug Discovery Partners, Inc.
November 5, 2026
Advancing Metabolic Disease Drug Development: Translational Models and a GLP-1 Receptor Agonist Metabolism Case Study
Sponsor:
BioIVT
November 5, 2026
A More Complete Picture of Antibody Function: Lessons from Comprehensive Fc Profiling of Approved Anti-CD20 Antibodies
Sponsor:
KACTUS
.avif)
November 5, 2026
AI-Ready, Lab-Proven: A New Standard for High-Throughput Antibody Characterization
Sponsor:
Biointron
November 5, 2026
Enhancing Clinical Predictability through Human Disease-relevant Preclinical Models in CNS and Muscle Drug Discovery
Sponsor:
Axcelead Drug Discovery Partners, Inc.
November 5, 2026
Structure is Strategy: Integrating Cryo‑EM, X‑ray, NMR and HDX‑MS for Precision Drug Discovery
Sponsor:
Novalix
November 5, 2026
New Approach Methodologies (NAMs): Key Considerations and Applications
Sponsor:
BioIVT
HUB Organoids
Evotec
November 5, 2026
From Clinical Data to Actionable Assets for Pharmaceutical R&D
Sponsor:
France Tissue Bank
November 5, 2026
Strategies to Optimize Commercialization of Oncology Treatments for Younger Adults
Sponsor:
ICON
November 5, 2026
Patient Data: Opportunities for Rare Diseases, Cell and Gene Therapies, and Oncology
November 5, 2026
Webinar Series: Early patient preferences for patient-focused drug development
November 5, 2026
Looking Beyond Survival Data: Understanding the Value of Non-OS Endpoints in Oncology Reimbursement Decision-Making
November 5, 2026
Detecting Early Synaptic Failure in Prion Disease Using Organoid Models
Sponsor:
Harvard Bioscience, Inc.
November 5, 2026
Improving Preclinical Decision-Making in Obesity and CKD with Translational In Vivo Phenotyping
Sponsor:
Axcelead Drug Discovery Partners, Inc.
November 5, 2026
Advancing the Manufacture of Mesenchymal Stromal Cells and Derived Extracellular Vesicles in Stirred-Tank Bioreactors Through Enhanced Bioprocess Control
Sponsor:
STEMCELL Technologies Inc.
November 5, 2026
From Genetic Validation to Relevant Target Engagement: Small Molecule Inhibitor Binding to 17β-HSD13
November 5, 2026
Bridging Mouse Models and Human Inflammatory Bowel Disease: in vivo Pharmacology, Histology and Biomarkers
Sponsor:
Novalix
November 5, 2026
Improving Confidence in Thyroid Hormone Disruption Assessment Using a Novel Human-Relevant In Vitro Model
Sponsor:
LifeNet Health LifeSciences
November 5, 2026
Accelerating Antibody Discovery: Integrating Microfluidics, HT Expression, and Early Developability Platform
Sponsor:
Biointron
November 5, 2026
Beyond Exposure: Integrating PK/PD for Translational Predictive Power
Sponsor:
Crown Bioscience
November 5, 2026
Screening the Unscreenable: Expanding the Reach of Drug Discovery
Sponsor:
SandboxAQ
November 5, 2026
Fulfilling the Gap: Innovative Critical Reagents for Non-Human Primate Preclinical Studies
Sponsor:
ABclonal Technology
November 5, 2026
Advancing ADC Development: Leveraging AI and Translational Preclinical Models to Improve Clinical Predictability
Sponsor:
Shanghai LIDE Biotech Co., Ltd. (LIDE Biotech)
November 5, 2026
Human iPSC-Derived Sensory Neurons for Functional Sensory Biology and Pharmacology Research
Sponsor:
BrainXell Inc.
November 5, 2026
From Biopsy to Better Decisions: Patient-Derived Organoids Predict Treatment Response in Metastatic Colorectal Cancer
Sponsor:
HUB Organoids
November 5, 2026
Accelerating Conjugation Process Development for Next-Generation ADCs: Key Considerations and Platform Strategies
Sponsor:
AsymBio
November 5, 2026
High-Throughput-qPCR and Transcriptomics: Powering the Next Generation of Drug Discovery
Sponsor:
Evotec
November 5, 2026
Epigenomics at 360 in Liquid Biopsy: Approaches and Case Studies for Biomarker Discovery and Drug Development
Sponsor:
Hologic Diagenode
November 5, 2026
The Sound of Science: Mapping the Tumor Microenvironment for Advanced Therapeutic Strategies
Sponsor:
FUJIFILM VisualSonics Inc.
November 5, 2026
Precision in Human Biological Samples: Leveraging Regulatory Rigor and Deep Data for Advanced Disease Research
Sponsor:
BioIVT
France Tissue Bank
November 5, 2026
Next-Generation TCR-Like Antibodies With Improved Specificity Profiles
Sponsor:
KACTUS
November 5, 2026
De-Risking Immunotherapy Targets with Next-Gen HLA Discovery Platforms
Sponsor:
HLA Protein Technologies Inc.
November 5, 2026
Clinical Applications of Optical Cerebral Blood Flow Imaging
Sponsor:
Openwater
November 5, 2026
ADCs on The Horizon: The Performance and Prospect of Cell Line Development Platform AmigoCHO
Sponsor:
AsymBio
November 5, 2026
Building New Approach Methodologies for Angiogenesis and Vascularized Models
Sponsor:
Lonza Bioscience
November 5, 2026
Using ALS Patient-Derived Motor Neurons to Study TDP-43 Mislocalization
Sponsor:
Ricoh Biosciences
November 5, 2026
hiPSC-Cardiomyocyte Platforms Enabling Comprehensive Cardiac Toxicity and Drug Efficacy Evaluation
Sponsor:
FUJIFILM Corporation
November 5, 2026
Protein-Protein Interaction (PPI) Landscape - Sequence-to-Affinity Heatmaps for High-Throughput Antibody Optimization
Sponsor:
PROTEINA
November 5, 2026
Human Biological Samples in Research: Quality, Compliance, and Clinical Relevance
Sponsor:
Crown Bioscience
November 5, 2026
Combination Therapy for Glioblastoma: A Personalized, AI-Driven Approach
Sponsor:
Certis Oncology Solutions, Inc.
November 5, 2026
In Vivo panCAR Therapy Using Circular RNA for the Treatment of Autoimmune Disease
Sponsor:
STEMCELL Technologies Inc.
November 5, 2026
From Single Domain to Single B: Leveraging Biointron's Expertise for Antibody Discovery Success
Sponsor:
Biointron
November 5, 2026
Beyond Checkpoints: Strategic Use of CDX Models in Emerging IO Therapies
Sponsor:
Crown Bioscience
November 5, 2026
Non CYP Mediated Metabolism Pathways and In Vitro Evaluation Strategies
Sponsor:
BioIVT
November 5, 2026
Uniting biology and digital drug discovery to identify new therapeutic opportunities in neurodegeneration
Sponsor:
Concept Life Sciences
November 5, 2026
Enhance Your Tissue Processing Efficiency with the STEMprep Tissue Dissociator
Sponsor:
STEMCELL Technologies Inc.
November 5, 2026
Novel Applications of the Cellular Thermal Shift Assay (CETSA) Provide New Insights for Drug Discovery
Sponsor:
Pelago Bioscience
November 5, 2026
Exploring the iPSC-Derived Neuronal-Glia Co-culture System: A Powerful Drug Discovery Platform for Studying Neurodegenerative Diseases
Sponsor:
FUJIFILM Corporation
November 5, 2026
Integrating Regulatory Guidance and Sustainable Skin Procurement for Consistent Execution of In Vitro Permeation Testing
Sponsor:
LifeNet Health LifeSciences
November 5, 2026
Launch Event: Propelling Boundaries - Innovative Technologies in Early Drug Discovery
Sponsor:
WuXi AppTec
November 5, 2026
Advances in Preclinical Research using Human Co-culture Models: Applications in Immunology, Infectious Disease, and Oncology
Sponsor:
Lonza Bioscience
November 5, 2026
Artificial Intelligence in Preclinical Research: Pathology, Biospecimens, and Model Selection
Sponsor:
Discovery Life Sciences
BioIVT
Certis Oncology Solutions, Inc.
November 5, 2026
CAR Finder - A Platform for Rapid CAR T Cell Screening
Sponsor:
Lonza Bioscience
November 5, 2026
CRISPR Gene Editing in Primary T Cells: A Case Study in the Fight Against HIV
Sponsor:
Lonza Bioscience
November 5, 2026
Improved Clearance Predictions for Aldehyde Oxidase Substrates Using TruVivo, a Novel Human Hepatocyte Model
Sponsor:
LifeNet Health LifeSciences
November 5, 2026
The Hidden Variable in Your Intestinal Organoids: Enhancing Differentiation for a More Predictive Model
Sponsor:
STEMCELL Technologies Inc.
November 5, 2026
Integrating Functionalized Multi-omics in Oncology Drug Discovery
Sponsor:
Champions Oncology
November 5, 2026
Fresh or Cryopreserved Leukopaks? Assessing the Impact of Different Storage Conditions on Leukopak Stability
Sponsor:
Charles River Cell Solutions
November 5, 2026
Breaking the Bottleneck: Harnessing Proteomics Services to Overcome Challenges in Clinical Research
Sponsor:
Standard BioTools
November 5, 2026
Leveraging Genomic, Preclinical, and Drug Response Data in the Age of AI
Sponsor:
Certis Oncology Solutions, Inc.
November 5, 2026
Biomarkers from Bench to Bedside: Tools, Targets, and Translational Insights
Sponsor:
Crown Bioscience
November 5, 2026
Discovery and Engineering of High-Affinity Soluble T Cell Receptors via a High-Throughput Yeast-Based Platform
Sponsor:
KACTUS
November 5, 2026
Innovative Rabbit Antibodies and Engineering for Therapeutics and Diagnostics
Sponsor:
Abwiz Bio Inc
November 5, 2026
High-Quality Mobilized Leukopaks to Enhance Your Cell and Gene Therapy Research and Development
Sponsor:
STEMCELL Technologies Inc.
November 5, 2026
Towards Eliminating Small Molecule Toxicity: Axiom's AI Models for Clinical Safety Assessment
Sponsor:
AxiomBio, Inc.
November 5, 2026
Considerations in Tissue Acquisition and Characterization for the Development of Long-Term Tumoroid Models
Sponsor:
Discovery Life Sciences
November 5, 2026
Advancing Your Innovation: Navigating the Complexity of Stable Cell Line Development
Sponsor:
ProteoGenix
November 5, 2026
Empowering Drug Hunters with High-Throughput Protein Crystallography
Sponsor:
Concept Life Sciences
November 5, 2026
Unraveling Immunotherapy Resistance in Advanced Melanoma: Novel Insights from Longitudinal Spatial Multiomics Studies
Sponsor:
Akoya Biosciences
November 5, 2026
Arrayed CRISPR screening for phenotypic discovery at the MRC-AstraZeneca-University of Cambridge Joint Functional Genomics Screening Laboratory (FGSL)
Sponsor:
Lonza Bioscience
November 5, 2026
Supporting the Development of Biologics Through the IND-Enabling Studies and Clinical Phases
Sponsor:
Pharmaron, Inc
November 5, 2026
Licensing Biological Materials: Crucial Considerations for Preclinical Researchers
Sponsor:
Crown Bioscience
November 5, 2026
Spatial Biology and the Gastrointestinal Tract: Unveiling Cellular Landscapes and Disease Mechanisms
Sponsor:
Akoya Biosciences
November 5, 2026
Meeting Ethical & Regulatory Requirements When Using Human Biological Specimens
Sponsor:
BioIVT
November 5, 2026
The ADMET Toolkit: Impact on Compound Design and Optimisation
Sponsor:
Concept Life Sciences
November 5, 2026
Deconstructing the Effects of Dietary Fat on Intestinal Cellular Networks
Sponsor:
Columbus Instruments
November 5, 2026
From Bench to Clinic: Decoding the IND Roadmap for Innovative Cell and Gene Therapies
November 5, 2026
Reprogramming the Brain Tumor Microenvironment to Enhance Anti-Tumor Immunity
Sponsor:
Akoya Biosciences
November 5, 2026
Illuminating Immunohistochemistry: Right-sizing Your Validation and Regulatory Strategy
Sponsor:
Precision for Medicine
November 5, 2026
A New Approach to Vector-Free CRISPR Editing Starting From Single Cells
Sponsor:
Cytosurge AG
November 5, 2026
Using In Vitro Assays to Model Complex Biology with PhenoVista's Assay Services
Sponsor:
PhenoVista Biosciences
November 5, 2026
Hematopoietic Stem Cell Fitness and Function During Sickle Cell Disease
Sponsor:
STEMCELL Technologies Inc.
November 5, 2026
Bringing Oncology Intelligence to Early Drug Development With AI-Powered Response Predictions
Sponsor:
Certis Oncology Solutions, Inc.
November 5, 2026
Illuminating Immunohistochemistry: From Biomarker to Clinical Trial Assay
Sponsor:
Precision for Medicine
November 5, 2026
Implementing the Colony-Forming Unit (CFU) Assay As a Potency Assay for Hematopoietic Cell Therapy Products
Sponsor:
STEMCELL Technologies Inc.
November 5, 2026
Applications of Humanized Mice in the Evaluation of Antibody-Drug Conjugates to Treat Autoimmune Diseases
Sponsor:
GemPharmatech
November 5, 2026
Innovative Approaches to Assessing Thyroid Disruption: The 3D Human Thyroid Microtissue Model
Sponsor:
LifeNet Health LifeSciences
November 5, 2026
Discover the Freshness of Frozen PBMCs - An Assessment of Cryopreservation Impact on T Cell Activation and Phenotype
Sponsor:
Lonza Group AG
関連コンテンツ
デモを見る
現代のライフサイエンスを支えるデジタル基盤
プロバイダー、ワークフロー、承認、コンプライアンス、データ、支出を一元管理できるインテリジェントなプラットフォームをご紹介します。複雑なプロジェクトをより迅速に、高い可視性と管理体制のもとで推進することが可能です。